Official statement from the production team of 'Yeon Ae (Dr.)': Director An Pan-seok has passed away; funeral arrangements will be held privately.

*This content was translated by AI.

Following the passing of director An Pan-seok (65), the production team of the drama 'Yeon Ae (Dr.)' expressed their condolences.

'Yeon Ae (Dr.)' announced in an official statement on the 12th that "we are deeply saddened to share this news. Director An Pan-seok passed away on August 12, 2026."

The statement continued: "In accordance with the wishes of the bereaved family, we are sharing this sad news. To allow the grieving family time to quietly say their final goodbyes to the deceased, we request your kind cooperation in keeping funeral arrangements private from the media. Once again, we extend our deepest condolences on the passing of the late director and respectfully pray for his eternal peace."

Director An Pan-seok, who had been battling brain hemorrhage after being diagnosed with lung cancer last year, passed away this afternoon as his condition worsened.

Director An Pan-seok collapsed from a brain hemorrhage last month and was hospitalized. At the time, his team stated he was "currently recovering," but we regret to share this tragic news.

The late director's final work is ENA's upcoming drama 'Yeon Ae (Dr.)', scheduled for broadcast in October. The romance series follows Min-jae, a doctoral student who lost one leg due to illness despite being a swimmer in high school, and Yu-jin, a master's student who wandered aimlessly after losing direction before finding a new path. Their story unfolds as they meet in a robotics research laboratory, starring actors Choi Young-woo and Kim So-hyun.

Director An Pan-seok directed dramas including 'White Tower', 'The Qualities of a Wife', 'Secret Love Affair', 'I Heard It Through the Grapevine', 'Pretty Noona Who Buys Me Food', 'Spring Night', and 'Negotiation Techniques'.

<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>

*This content was translated by AI.